Home › Relapsing-Remitting Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis clinical trials recruiting in the U.S.
18 studies for Relapsing-Remitting Multiple Sclerosis are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
RecruitingPhase 3
Ages 18 to 55 · All sexes · Updated Sep 16, 2026 · NCT04047628Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
Recruiting
Ages 18 to 65 · All sexes · Updated Sep 15, 2026 · NCT05958381Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 10, 2026 · NCT06408259The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Recruiting
Ages 22 to 60 · All sexes · Updated Sep 2, 2026 · NCT06796504Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
RecruitingObservational study
Ages 40 to 70 · All sexes · Updated Aug 11, 2026 · NCT07758270Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
Recruiting
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT06864936Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
RecruitingPhase 1/2
Ages 18 to 55 · All sexes · Updated Jul 2, 2026 · NCT05359653Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
Recruiting
Ages 45 to 89 · All sexes · Updated Jun 17, 2026 · NCT06919900Intermittent Hypoxia in Persons With Multiple Sclerosis
Recruiting
Ages 18 to 75 · All sexes · Updated Mar 20, 2026 · NCT06276634Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Mar 17, 2026 · NCT07225361Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
Recruiting
Ages 18 to 100 · All sexes · Updated Mar 6, 2026 · NCT07376772Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Recruiting
Ages 18 to 75 · All sexes · Updated Feb 23, 2026 · NCT06390930Effects of Ublituximab on Motor Functions in Multiple Sclerosis
RecruitingEarly phase 1
Ages 18 to 55 · All sexes · Updated Feb 9, 2026 · NCT06629428Home Based Functional Balance Intervention for Multiple Sclerosis
Recruiting
Ages 40 to 90 · All sexes · Updated Jan 21, 2026 · NCT07355387"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 31, 2025 · NCT07222618Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2025 · NCT05964829MS-ResearchBiomarkerS
RecruitingObservational studyHealthy volunteers welcomeMentions payment for participants
Ages 18 and older · All sexes · Updated Feb 6, 2024 · NCT05204459Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
RecruitingObservational study
Ages 18 to 60 · All sexes · Updated Jun 6, 2022 · NCT04458688From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.